TrialJournal of the American Society of Nephrology : JASN2020

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.

Tadao Akizawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.